baclofen has been researched along with Obesity in 6 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the anti-obesity effects of baclofen in the present study were mild, this pilot study suggests the possibility that baclofen might serve as a new anti-obesity drug in humans." | 9.14 | Positive effect of baclofen on body weight reduction in obese subjects: a pilot study. ( Arima, H; Oiso, Y, 2010) |
| "Although the anti-obesity effects of baclofen in the present study were mild, this pilot study suggests the possibility that baclofen might serve as a new anti-obesity drug in humans." | 5.14 | Positive effect of baclofen on body weight reduction in obese subjects: a pilot study. ( Arima, H; Oiso, Y, 2010) |
| " In BED with obesity or overweight, bupropion may cause mild weight loss without seizures, and chromium may improve glucose regulation." | 4.91 | Psychopharmacologic treatment of eating disorders: emerging findings. ( Guerdjikova, AI; Keck, PE; McElroy, SL; Mori, N, 2015) |
| " Minute ventilation (Ve), tidal volume (Vt), and breathing frequency (f) during room air breathing and in response to 10 min of hypercapnia (8% CO(2)) and 30 min of hypoxia (10% O(2)) were measured by the barometric method, and peak oxygen consumption (Vo(2 peak)) was measured by an enclosed metabolic treadmill following the randomized blinded subcutaneous administration of equal volumes of DMSO (vehicle), bicuculline (selective GABA(A) receptor antagonist, 1 mg/kg), and phaclofen (selective GABA(B) receptor antagonist, 1 mg/kg)." | 3.74 | GABA(A) and GABA(B) receptors differentially modulate volume and frequency in ventilatory compensation in obese Zucker rats. ( Chen, JS; Huang, CY; Lee, SD; Lo, MJ; Ting, H; Yang, AL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, R | 1 |
| Tsunekawa, T | 1 |
| Hirose, T | 1 |
| Yaginuma, H | 1 |
| Taki, K | 1 |
| Mizoguchi, A | 1 |
| Miyata, T | 1 |
| Kobayashi, T | 1 |
| Sugiyama, M | 1 |
| Onoue, T | 1 |
| Takagi, H | 1 |
| Hagiwara, D | 1 |
| Ito, Y | 1 |
| Iwama, S | 1 |
| Suga, H | 1 |
| Banno, R | 2 |
| Bettler, B | 1 |
| Arima, H | 3 |
| McElroy, SL | 1 |
| Guerdjikova, AI | 1 |
| Mori, N | 1 |
| Keck, PE | 1 |
| Oiso, Y | 2 |
| Yang, AL | 1 |
| Lo, MJ | 1 |
| Ting, H | 1 |
| Chen, JS | 1 |
| Huang, CY | 1 |
| Lee, SD | 1 |
| Sato, I | 1 |
| Ozaki, N | 2 |
| Watanabe, M | 1 |
| Goto, M | 1 |
| Shimizu, H | 1 |
| Hayashi, M | 1 |
| Nagasaki, H | 1 |
| Abramson, SI | 1 |
| Holmes, AA | 1 |
| Hagberg, CA | 1 |
1 review available for baclofen and Obesity
| Article | Year |
|---|---|
Psychopharmacologic treatment of eating disorders: emerging findings.
Topics: Administration, Intranasal; Anorexia Nervosa; Anti-Obesity Agents; Antidepressive Agents, Second-Gen | 2015 |
1 trial available for baclofen and Obesity
| Article | Year |
|---|---|
Positive effect of baclofen on body weight reduction in obese subjects: a pilot study.
Topics: Adiponectin; Adult; Animals; Anti-Obesity Agents; Appetite; Baclofen; Blood Glucose; Blood Pressure; | 2010 |
4 other studies available for baclofen and Obesity
| Article | Year |
|---|---|
GABA
Topics: Animals; Baclofen; Bulimia; Diet, High-Fat; Disease Models, Animal; Dopaminergic Neurons; Female; GA | 2021 |
GABA(A) and GABA(B) receptors differentially modulate volume and frequency in ventilatory compensation in obese Zucker rats.
Topics: Animals; Baclofen; Bicuculline; Dimethyl Sulfoxide; GABA Antagonists; Hypercapnia; Hypoxia; Male; Ob | 2007 |
Peripherally administered baclofen reduced food intake and body weight in db/db as well as diet-induced obese mice.
Topics: Adipokines; Adipose Tissue, White; Administration, Oral; Animals; Anti-Obesity Agents; Arcuate Nucle | 2007 |
Awake insertion of the Bonfils Retromolar Intubation Fiberscope in five patients with anticipated difficult airways.
Topics: Accidents, Traffic; Adult; Aged; Baclofen; Body Size; Cervical Vertebrae; Equipment Design; Fiber Op | 2008 |